Our market access experts provide an overview of how to get payer scientific advice between Septembe...
Read moreWe explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...
Read moreOur experts discuss the latest news and updates on the EU HTA process, including implications for ma...
Read moreOur clients have been developing new drugs for crowded, rapidly evolving therapy areas, with uncerta...
Read moreOncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read moreWe summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreOur market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh...
Read moreWebinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...
Read more